Contineum Therapeutics CTNM
NASDAQ CTNM
$16.70 -0.87 (-4.95%)
As of: Sep 4, 2026 · 3:59 PM EDT

Contineum Therapeutics (CTNM) Market Capitalization (2024 - 2026)

Analysis

Contineum Therapeutics (CTNM) Market Capitalization (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Contineum Therapeutics 628.71 Mn 628.71 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 614.10 Mn
Mar 31, 2026 487.65 Mn
Dec 31, 2025 426.57 Mn
Sep 30, 2025 342.89 Mn
Jun 30, 2025 102.81 Mn
Mar 31, 2025 180.57 Mn
Dec 31, 2024 378.77 Mn
Sep 30, 2024 492.47 Mn
Jun 30, 2024 452.99 Mn